The CVS Health Aspirin 81 mg. Low-dose tablets for daily heart protection

CVS Health Aspirin 81 mg sits near the back of the pharmacy aisle, in a matte red-and-white box that feels slightly rough when you run your thumb across the cardboard flap. Each tiny, light-yellow tablet is designed for daily use, and CVS chief medical officer Dr. Sree Chaguturu routinely points to low-dose aspirin as a long-standing tool in cardiovascular care when used according to current guidelines.

Low-dose aspirin, clearly labeled

The CVS Health Aspirin 81 mg product is a store-brand low-dose aspirin, containing 81 milligrams of acetylsalicylic acid per tablet, marketed primarily for cardiovascular prevention in adults under medical guidance. According to the CVS Pharmacy product listing, the tablets are enteric-coated, intended to dissolve in the intestine rather than the stomach, which can help reduce direct gastric irritation compared with uncoated aspirin.

On the shelf and online, CVS clearly flags that this low-dose aspirin is not a simple painkiller substitute, but a medication typically used for long-term prevention of heart attack and certain stroke types in patients for whom a clinician has recommended daily aspirin therapy. The front of the box highlights the 81 mg strength, while the drug facts panel spells out the active ingredient, recommended use, and warnings about bleeding risk and interactions with other medicines such as anticoagulants or NSAIDs.

Formulation, dosage and safety

The CVS packaging and online description specify that each tablet contains 81 mg of aspirin and uses an enteric coating, described as a special polymer layer that withstands stomach acid and breaks down later in the gastrointestinal tract. This design is common in low-dose aspirin products aimed at long-term cardiovascular prevention; it allows slow release while attempting to limit stomach discomfort in sensitive users.

CVS recommends that consumers follow healthcare provider instructions on daily dose and duration, rather than starting or stopping aspirin therapy on their own. The product’s drug facts detail that adults may take one tablet daily with a full glass of water, but they underline that the medicine is not intended for occasional pain relief in the way higher-dose aspirin or ibuprofen might be used. The warning panel specifically calls out increased risk of bleeding, including gastrointestinal bleeding and hemorrhagic stroke, and cautions against use in children or teenagers with viral infections due to the risk of Reye’s syndrome.

Position in the CVS pharmacy aisle

CVS Health sells this 81 mg aspirin in multiple pack sizes, with common formats including 120-count and 300-count bottles, reflecting the long-term use pattern for patients on daily therapy. Pricing varies by location and promotions, but US retail listings show that store-brand low-dose aspirin typically undercuts comparable national-brand products such as Bayer in per-tablet cost, which matters for chronic use over years. The packaging deliberately mirrors national-brand color schemes, while the CVS logo and "Health" sub-brand signal a value-focused, pharmacy-backed alternative.

Within the cardiovascular segment, CVS stocks both branded and generic options for cholesterol, blood pressure and antiplatelet therapies, yet in the over-the-counter section, low-dose aspirin remains a foundational self-directed product. Pharmacist counseling often bridges the gap between prescription cardiology care and self-care choices, and store-brand aspirin gives CVS a direct margin contribution in that space. The company’s promotional materials emphasize accessibility, with most US CVS Pharmacy locations carrying the product on-site and online ordering available through the cvs.com platform.

Guideline backdrop and changing use patterns

Daily low-dose aspirin once featured heavily in general wellness messaging, but updated clinical guidelines have narrowed its recommended use. The US Preventive Services Task Force (USPSTF) has advised that routine initiation of daily aspirin for primary prevention in older adults should be approached cautiously, balancing potential benefit against bleeding risk. As a result, CVS and other pharmacy chains have shifted their communication toward emphasising consultation with a clinician before starting therapy, rather than portraying aspirin as a universal heart-protection strategy.

Dr. Sree Chaguturu has publicly discussed CVS Health’s broader aim of aligning retail offerings with evidence-based care, including ensuring that cardiovascular-related OTC products do not run counter to current medical recommendations. Low-dose aspirin remains firmly in the portfolio, but the company’s health content and pharmacist training stress risk awareness and the importance of individualized decisions, particularly for patients over 60 or with higher bleeding risk. This nuanced messaging shapes how the product appears on cvs.com, where warning language and direction to consult a doctor feature prominently alongside price and pack-size information.

Production, sourcing and regulatory framework

CVS Health, as a major US pharmacy and healthcare company headquartered in Woonsocket, Rhode Island, contracts with pharmaceutical manufacturers to produce its store-brand aspirin under strict quality standards. While the specific contract manufacturer for CVS Health Aspirin 81 mg is not prominently advertised at the point of sale, the box states that the product is distributed by CVS Pharmacy and complies with US Food and Drug Administration (FDA) requirements for over-the-counter drug labeling and formulation.

CVS’s broader store-brand medicines, including aspirin, typically fall under its quality-assurance program that claims adherence to United States Pharmacopeia (USP) standards, ensuring tablet content uniformity, dissolution characteristics, and impurity limits that match or exceed national-brand benchmarks. This quality positioning is important for a product intended for daily use in patients at cardiovascular risk, where consistency and reliability matter as much as price. In investor presentations, CVS highlights its private-label growth as a margin driver across health and wellness categories.

Revenue role and the CVS Health share

Low-dose aspirin does not capture headlines like new biologic drugs or specialty pharmacy services, but it sits inside a broad preventive-care basket that generates steady foot traffic and online orders for CVS. The cardiovascular prevention category brings repeat purchases and encourages pharmacy consultations, which in turn can connect patients to the company’s primary care offerings and prescription services. For a retailer focused on integrating pharmacy, insurance and care delivery, reliable OTC staples such as CVS Health Aspirin 81 mg help weave patients into that ecosystem.

CVS Health Corp. stock (ISIN US1266501006) trades on the New York Stock Exchange, and analysts following the company’s results often point to front-of-store and private-label performance as part of its diversified revenue mix, even if low-dose aspirin itself is a small sub-segment in financial terms.